AI analysis of one-year CT changes predicts disease progression and survival in fibrotic interstitial lung disease.
Key Details
- 1Researchers at National Jewish Health used an AI-based tool to detect subtle increases in lung fibrosis on serial CT scans.
- 2A 5% or more increase in fibrosis score over one year doubled the risk of death or lung transplant for patients.
- 3AI-derived fibrosis changes predicted steeper lung function decline, especially in patients with less severe baseline disease.
- 4The deep learning method, data-driven textural analysis (DTA), provided precise, objective fibrosis quantification.
- 5Results were validated with data from the Pulmonary Fibrosis Foundation Patient Registry, demonstrating generalizability.
- 6Quantitative CT analysis could be used for trial endpoints and real-world risk stratification.
Why It Matters
This study demonstrates the clinical potential of deep learning-based CT quantification for early risk identification and outcome prediction in fibrotic lung disease. It supports wider use of imaging AI as an objective, reproducible tool for prognosis and treatment decision-making in complex pulmonary disorders.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.